DISHMAN CARBOGEN AMCIS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 171 INR | -0.73% |
|
-4.74% | +0.09% |
| 06-28 | Dishman Carbogen Amcis Receives FDA Clearance for Swiss Manufacturing Facilities | MT |
| 05-31 | Transcript : Dishman Carbogen Amcis Limited, Q4 2024 Earnings Call, May 31, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 809B | ||||||
| 624B | ||||||
| 351B | - | - | - | - | ||
| 319B | ||||||
| 289B |
